HomeCLLS • NASDAQ
add
Cellectis SA
Nakaraang pagsara
$1.51
Sakop ng araw
$1.48 - $1.56
Sakop ng taon
$1.10 - $3.38
Market cap
115.30M USD
Average na Volume
594.73K
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 15.16M | 662.06% |
Gastos sa pagpapatakbo | 25.84M | -14.79% |
Net na kita | 5.92M | 114.17% |
Net profit margin | 39.05 | 101.86% |
Kita sa bawat share | -0.16 | 71.93% |
EBITDA | -7.45M | 71.79% |
Aktuwal na % ng binabayarang buwis | 7.99% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 143.25M | 4.79% |
Kabuuang asset | 383.54M | 14.74% |
Kabuuang sagutin | 252.51M | 1.18% |
Kabuuang equity | 131.03M | — |
Natitirang share | 72.09M | — |
Presyo para makapag-book | 0.83 | — |
Return on assets | -6.85% | — |
Return on capital | -12.17% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 5.92M | 114.17% |
Cash mula sa mga operasyon | -47.00K | -100.12% |
Cash mula sa pag-invest | -16.66M | -22.04% |
Cash mula sa financing | 2.92M | -92.97% |
Net change in cash | -15.84M | -122.84% |
Malayang cash flow | -10.65M | -131.67% |
Tungkol
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina. Wikipedia
Itinatag
1999
Website
Mga Empleyado
219
